Depression is a common disorder, but we still do not understand its exact
pathogenesis. In recent years, the interest in the role of gut microbiota has
increased. The microbiota–gut–brain axis describes the connection between the
gastrointestinal system and the central nervous system, involving neural, immune,
and metabolic pathways. This review aims to present current knowledge on this
relationship. Research has shown that patients with major depressive disorder
(MDD) have a distinct gut microbiota structure compared to healthy individuals.
Similar observations come from animal studies. Researchers observed that
transplantation of microbiota from depressed individuals may induce depressivelike
behavior in experimental models. Several mechanisms may explain this
association. These include increased inflammatory activity, disturbances in
tryptophan metabolism, and changes in neuroendocrine function. There are also
studies suggesting that modifying the gut microbiota, for example, with probiotics
or fecal microbiota transplantation, may have a positive effect on depressive
symptoms. In conclusion, current data suggest that gut microbiota may play a role
in depression. However, further studies are needed to understand these
mechanisms better and to evaluate their possible clinical use.
Keywords: gut microbiota, depression, major depressive disorder, gut-brain axis,
and inflammation.
